News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Red circle around the letter "I" shows an artist's interpretation of a request for information

NCI Seeks Feedback on Data Sharing Processes

Working with cancer data? NCI’s Office of Data Sharing invites you to give feedback on the processes you use to manage and share data.

MRI image of the prostate showing segmentation of the core and peripheral zones.

New Contract Opportunity to Obtain Medical Image Segmentations

NCI is seeking support for developing machine-generated segmentations of images in the radiology collections of the Imaging Data Commons (IDC). Submit your proposals by March 10, 2023.

An open laptop displays a colored line graph. The computer is surrounded by icons representing various forms of data visualization, such as pie charts and bar charts. Percentages, gear cogs, and a magnifying glass are also present.

Apply for Grants to Support Novel and Standard Tools for Analyzing All of Us Program Data

NIH and NCI are participating in two funding opportunities to support the All of Us Research Program’s Researcher Workbench. These grants will help support analysis of the data for this program to advance research in cancer risk, early detection, prevention, diagnosis, treatment, cancer control, epidemiology, and health disparities.

Blue and white graphic with hexagonal pattern, "Funding Opportunity Available"

Apply by February 13 for Supplemental Funds to Support Data Science Training

You can use the funding to support data science training related to research on infectious- and immune-mediated disease, including cancer.

Figure shows CT scans and corresponding 3-D renderings of tumor vasculature for people who responded to therapy vs. those who didn't. Tumor vasculature in non-responders had more twists and turns than those who responded to treatment.

Tumor Twistedness Serves as AI-Based Biomarker for Lung Cancer Immunotherapy

Using data from routine lung scans, NCI-supported researchers developed an AI-based tool to help predict how patients will respond to therapy.

Closeup of the word 'data' in a dictionary.

Winter 2022 Updates to Semantic Products of NCI Enterprise Vocabulary Services

The latest release from NCI’s Enterprise Vocabulary Services includes updates to SeroNet terminology, childhood neoplasm terminologies, as well as other standalone terminologies, ontologies, and mappings.

Text reads, "Funding Opportunity," overlaid on a blue and grey-scale repeating triangular pattern.

Apply to Provide Statistical and Data Management Support to the NCI Cancer Screening Research Network

This new cancer screening research network will require a team that can lead data management, quality control, and reporting activities of its clinical trials and studies. To be that team, apply as soon as January 28 but no later than February 28, 2023!

Drawing of a website with wrenches, gears, and tools to illustrate that upgrades are being made.

Childhood Cancer Data Initiative’s Molecular Targets Platform Gets Upgrade

Researchers seeking potential targets for treating childhood cancers now have an even better tool for the job. Check out the latest enhancements to the NCI Childhood Cancer Data Initiative’s (CCDI’s) Molecular Targets Platform.

Blue background with white text that reads, "Supplemental Funding Opportunity Available"

Apply for Supplemental Funds to Support Data Sharing Ecosystem

Funding can be used to support data preparation for inclusion in the National Institute of Allergy and Infectious Diseases (NIAID) Data Ecosystem.

Stylized image shows a strand of DNA next to a drawing of a liver. Illustrates the idea that DNA may aid in detecting liver cancer.

DNA Fragmentome Data—A New Omics AI Technology for Detecting Cancer

NCI-funded researchers validated a genome-wide artificial intelligence technology that could help in early detection of hepatocellular carcinoma—the most common type of liver cancer.

SUBSCRIBE TO UPDATES

Categories

Archive